HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Freeman Launches Leverage Equity Of Eponymous Cosmetics Brand

This article was originally published in The Rose Sheet

Executive Summary

Freeman Beauty is pursuing an expansive product launch strategy that leverages the equity of its re-acquired Freeman Cosmetic business, according to the pH Beauty Labs division

You may also be interested in...



Freeman Grows Portfolio With Skin Care, Hair Care Ranges

Freeman Feeling Beautiful is a range of naturally positioned products for face and body that center on the idea of making women "look and feel" their best, according to Freeman Beauty

Freeman Grows Portfolio With Skin Care, Hair Care Ranges

Freeman Feeling Beautiful is a range of naturally positioned products for face and body that center on the idea of making women "look and feel" their best, according to Freeman Beauty

Freeman Beauty Labs

Private equity fund Champlain Capital invests $8.5 mil. in Freeman Beauty Labs, a transaction that will help Freeman grow its business following the repurchase of Freeman Cosmetic brand this year, company announces. "With all the consolidation of marketers and retailers, we feel we are poised for significant growth, with the help of Champlain," firm notes. Freeman repurchased its namesake brand two years ago, after selling it to Dial in 1998. In an effort to rebuild the collection, Freeman is embarking on an expansive product launch strategy while rationalizing SKUs and developing a growth plan (1"The Rose Sheet" Aug. 15, 2005, p. 3)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel